HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Circulating leptin correlates with left ventricular mass in morbid (grade III) obesity before and after weight loss induced by bariatric surgery: a potential role for leptin in mediating human left ventricular hypertrophy.

AbstractCONTEXT:
Obesity is frequently associated with left ventricular hypertrophy, even when uncomplicated by hypertension or diabetes mellitus. Left ventricular hypertrophy is an important risk factor for congestive heart failure.
OBJECTIVE:
The objective of this study was to evaluate the relationship between leptin and left ventricular mass in uncomplicated, morbid (grade 3) obesity and the existence of leptin receptors and intracellular signaling proteins in the human heart.
DESIGN:
Left ventricular mass (LVM) was calculated through electrocardiogram reading in normotensive grade III obese patients (World Health Organization classification) undergoing bariatric surgery [laparoscopic adjustable gastric banding (LAGB)] at baseline and 1 yr later. The control group was composed of healthy lean normotensive subjects. Leptin receptors were detected by PCR and immunocytochemistry in human heart biopsies.
SETTING:
This study was performed at university hospitals.
PATIENTS:
Thirty-one grade 3 obese patients and 30 healthy nonobese normotensive, age- and sex-matched control subjects were studied.
INTERVENTION:
Obese subjects underwent LAGB to induce weight loss and were evaluated at baseline and after 1 yr.
RESULTS:
LVM, plasma leptin, glucose, insulin levels, and homeostasis model assessment index were higher in obese than in lean controls (P < 0.01); at univariate regression analysis, LVM correlated with body mass index, leptin, and homeostasis model assessment index; at multiple regression analysis, LVM only correlated with leptin levels (P = 0.001). Obese subjects were reevaluated 1 yr after LAGB, when their body mass index changed from 46.2 +/- 1.24 to 36.6 +/- 1.05 kg/m(2) (P < 0.01); the decrease in LVM correlated only with the decrease in leptin levels (P < 0.01). We demonstrated that long and short isoforms of the leptin receptor and intracellular proteins mediating leptin signaling were expressed in human heart by RT-PCR, immunocytochemistry, or both methods.
CONCLUSIONS:
These data suggest that leptin could contribute to the left ventricular hypertrophy in humans.
AuthorsLucia Perego, Pierluigi Pizzocri, Domenico Corradi, Francesco Maisano, Michele Paganelli, Paolo Fiorina, Michelangela Barbieri, Alberto Morabito, Giuseppe Paolisso, Franco Folli, Antonio E Pontiroli
JournalThe Journal of clinical endocrinology and metabolism (J Clin Endocrinol Metab) Vol. 90 Issue 7 Pg. 4087-93 (Jul 2005) ISSN: 0021-972X [Print] United States
PMID15855267 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • LEPR protein, human
  • Leptin
  • Receptors, Cell Surface
  • Receptors, Leptin
Topics
  • Adult
  • Body Mass Index
  • Female
  • Humans
  • Hypertrophy, Left Ventricular (etiology)
  • Leptin (blood, physiology)
  • Male
  • Obesity, Morbid (blood, surgery)
  • Receptors, Cell Surface (analysis)
  • Receptors, Leptin
  • Regression Analysis
  • Weight Loss

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: